Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2011 | |
| Cash Flows From Operating Activities | |
| Net Income | -3,841 |
| Depreciation Amortization | 37 |
| Accounts payable and accrued liabilities | 2 |
| Other Working Capital | 799 |
| Other Operating Activity | -24 |
| Operating Cash Flow | $-3,027 |
| Cash Flows From Investing Activities | |
| PPE Investments | -40 |
| Investing Cash Flow | $-40 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -23 |
| Other Financing Activity | 7,314 |
| Financing Cash Flow | $7,291 |
| Beginning Cash Position | 6,891 |
| End Cash Position | 11,115 |
| Net Cash Flow | $4,224 |
| Free Cash Flow | |
| Operating Cash Flow | -3,027 |
| Capital Expenditure | -40 |
| Free Cash Flow | -3,067 |